N,N-dimethyl-2-sulfanylbenzamide;o-mercapto-N,N-dimethylbenzamide;EINECS 244-094-3;2-Mercapto-N,N-dimethylbenzamide;N,N-Dimethyl-2-mercaptobenzamide;BenzaMide, 2-Mercapto-N,N-diMethyl-
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Axitinib Impurity refers to <strong>chemical byproducts</strong> or <strong>synthetic intermediates</strong> associated with the manufacture of Axitinib, a tyrosine kinase inhibitor. These impurities are critical for process control and regulatory compliance in pharmaceutical production. The primary structure typically matches specific degradation pathways or side reactions during synthesis.</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Control:</strong> Used as reference standards for HPLC method validation and assay accuracy.</li>
<li><strong>R&D:</strong> Essential for identifying degradation products during stability studies.</li>
<li><strong>Regulatory Filing:</strong> Required for ICH Q3A/B guidelines documentation in drug master files.</li>
</ul>
<h3>Precautions</h3>
<p>Store under <strong>inert atmosphere</strong> at controlled temperatures below -20°C to prevent degradation. Strictly adhere to safety data sheets regarding skin contact and inhalation risks. Not intended for direct clinical use; handling requires certified laboratory protocols.</p>